VanEck Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Buy |
2,832
+448
| +19% | +$23.3K | ﹤0.01% | 1277 |
|
|
2025
Q1 | $102K | Sell |
2,384
-503
| -17% | -$21.5K | ﹤0.01% | 1278 |
|
|
2024
Q4 | $88K | Buy |
2,887
+929
| +47% | +$28.3K | ﹤0.01% | 1277 |
|
|
2024
Q3 | $40K | Sell |
1,958
-897
| -31% | -$18.3K | ﹤0.01% | 1282 |
|
|
2024
Q2 | $82K | Sell |
2,855
-83
| -3% | -$2.38K | ﹤0.01% | 1263 |
|
|
2024
Q1 | $61K | Buy |
2,938
+236
| +9% | +$4.9K | ﹤0.01% | 1269 |
|
|
2023
Q4 | $73K | Buy |
2,702
+614
| +29% | +$16.6K | ﹤0.01% | 1266 |
|
|
2023
Q3 | $62K | Buy |
2,088
+187
| +10% | +$5.55K | ﹤0.01% | 1264 |
|
|
2023
Q2 | $68K | Buy |
1,901
+254
| +15% | +$9.09K | ﹤0.01% | 1280 |
|
|
2023
Q1 | $39K | Sell |
1,647
-83,518
| -98% | -$1.98M | ﹤0.01% | 1319 |
|
|
2022
Q4 | $2.32M | Buy |
85,165
+12,973
| +18% | +$353K | 0.01% | 648 |
|
|
2022
Q3 | $3.89M | Sell |
72,192
-26,851
| -27% | -$1.45M | 0.01% | 486 |
|
|
2022
Q2 | $4M | Buy |
99,043
+1,743
| +2% | +$70.3K | 0.01% | 514 |
|
|
2022
Q1 | $6.45M | Sell |
97,300
-29,217
| -23% | -$1.94M | 0.01% | 454 |
|
|
2021
Q4 | $12.7M | Sell |
126,517
-5,173
| -4% | -$517K | 0.03% | 327 |
|
|
2021
Q3 | $16.5M | Sell |
131,690
-24,942
| -16% | -$3.12M | 0.04% | 274 |
|
|
2021
Q2 | $19.5M | Buy |
156,632
+8,331
| +6% | +$1.03M | 0.05% | 254 |
|
|
2021
Q1 | $22.6M | Buy |
148,301
+2,636
| +2% | +$402K | 0.06% | 212 |
|
|
2020
Q4 | $18.8M | Buy |
145,665
+7,792
| +6% | +$1M | 0.05% | 214 |
|
|
2020
Q3 | $15.4M | Buy |
137,873
+1,399
| +1% | +$156K | 0.05% | 211 |
|
|
2020
Q2 | $11.1M | Buy |
136,474
+46,031
| +51% | +$3.73M | 0.04% | 242 |
|
|
2020
Q1 | $6.3M | Sell |
90,443
-8,184
| -8% | -$570K | 0.03% | 279 |
|
|
2019
Q4 | $7.71M | Buy |
98,627
+11,156
| +13% | +$872K | 0.03% | 301 |
|
|
2019
Q3 | $5.58M | Buy |
+87,471
| New | +$5.58M | 0.03% | 323 |
|